Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases (Q35618816)

9 August 2017

title

Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases (English)

1 reference

9 August 2017

Harry W Flynn

1 reference

9 August 2017

Darlene Miller

1 reference

9 August 2017

Ingrid U Scott

1 reference

9 August 2017

Matthew S Benz

1 reference

9 August 2017

Nichard Unonius

series ordinal

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

American Journal of Ophthalmology

9 August 2017

published in

1 reference

9 August 2017

volume

137

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

38-42

1 reference

Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Delayed-onset endophthalmitis associated with conjunctival filtering blebs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Practice styles and preferences of ASCRS members--2000 survey. American Society of Cataract and Refractive Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Aqueous and vitreous penetration of levofloxacin after oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Vitreous and aqueous penetration of orally administered gatifloxacin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900896-1

10.1016/S0002-9394(03)00896-1

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference